A viable alternative to classical media supplemented with 10% FBS is reduced-serum media formulations. These formulations of classical media types, such as DMEM and RPMI, are nutritionally enhanced using the natural components of serum, including lipids, growth factors and proteins, which allow the use of serum to be reduced as low as 2% depending on cell type. Additionally, the reduced serum content in a user’s media helps to reduce any variability in their cell culture due to variability in serum batches, enabling a more flexible process.
The HyClone range of reduced-serum media, along with the full HyClone portfolio of media, serum, buffers and process supplements, is distributed in Australia by In Vitro Technologies. The company provides full product support for the range including serum batch testing support and media customisation.
Phone: 03 9771 3700
ProImmune ProVE SL Self-Loading MHC Class I Monomers
The novel reagents for antigen-specific CD8+ T cell detection are designed to offer...
HAWK Biosystems Quantifying Functions in Proteins (QF-Pro) reagent kits
HAWK Biosystems' Quantifying Functions in Proteins (QF-Pro) reagent kits contain the tailored...
Amsbio validated cytokines for organoid culture
Amsbio has launched over a range of over 30 independently developed and manufactured organoid...
